New drug trial aims to stabilize dangerous heart plaque
NCT ID NCT06863545
Summary
This study is testing whether adding a PCSK9 inhibitor drug to standard cholesterol-lowering therapy is better at preventing serious heart and stroke events in people with high-risk plaque in their heart arteries. The plaque is identified using a special, non-invasive CT scan. Researchers will compare the new combination treatment against standard therapy alone in about 3,600 participants over two years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hangzhou Linping First People's Hospital
RECRUITINGHangzhou, China
Contact
-
Jinhua Central Hospital
RECRUITINGJinhua, China
Contact
-
Seoul National University Hospital
NOT_YET_RECRUITINGSeoul, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Second Affiliated Hospital, School of Medicine, Zhejiang University
RECRUITINGHangzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Zhejiang Hospital
RECRUITINGHangzhou, China
Contact
-
Zhejiang Provincial Hospital of Traditional Chinese Medicine
RECRUITINGHangzhou, Zhejiang, China
Contact
Conditions
Explore the condition pages connected to this study.